Reduction of factor FVIIa activity during heparin therapy. Evidence for assay interactions with tissue factor pathway inhibitor and antithrombin.
A novel anticoagulant activity assay of tissue factor pathway inhibitor I (TFPI).
A simple chromogenic substrate assay of tissue factor pathway inhibitor activity in plasma and serum.
Associations of tissue factor and tissue factor pathway inhibitor with organ dysfunctions in septic shock.
Lehner GF, Tobiasch AK, Perschinka F, Mayerhöfer T, Waditzer M, Haller V, Zassler B, Maier S, Ulmer H, Joannidis M.
Sci Rep. 2024 Jun 24;14(1):14468. doi: 10.1038/s41598-024-65262-3.
Tissue Factor Pathway Inhibitor: Multiple Anticoagulant Activities for a Single Protein.
Mast AE.
Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):9-14. doi: 10.1161/ATVBAHA.115.305996. Epub 2015 Nov 24.
The Impact of Anticoagulant Activity of Tissue Factor Pathway Inhibitor Measured by a Novel Functional Assay for Predicting Deep Venous Thrombosis in Trauma Patients: A Prospective Nested Case-Control Study.
Cao X, Su Y, Zhang W, Zhao H, Wen M, Lu S, Zhao Y, Chen Y, Liu L, Zang X, Wu J.
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211063877. doi: 10.1177/10760296211063877.
Tissue factor pathway inhibitor: structure-function.
Broze GJ Jr, Girard TJ.
Front Biosci (Landmark Ed). 2012 Jan 1;17(1):262-80. doi: 10.2741/3926.
Tissue factor pathway inhibitor: then and now.
Ellery PE, Adams MJ.
Semin Thromb Hemost. 2014 Nov;40(8):881-6. doi: 10.1055/s-0034-1395153. Epub 2014 Nov 6.
Tissue factor pathway inhibitor activity in severe sepsis.
Creasey AA, Reinhart K.
Crit Care Med. 2001 Jul;29(7 Suppl):S126-9. doi: 10.1097/00003246-200107001-00038.
Increased tissue factor pathway inhibitor activity in IDDM patients with nephropathy.
Yokoyama H, Myrup B, Rossing P, Ostergaard PB.
Diabetes Care. 1996 May;19(5):441-5. doi: 10.2337/diacare.19.5.441.
Tissue factor pathway inhibitor: regulation of its inhibitory activity by phospholipid surfaces.
Lindhout T, Salemink I, Valentin S, Willems GM.
Haemostasis. 1996 Oct;26 Suppl 4:89-97. doi: 10.1159/000217289.
Genetic determinants of tissue factor pathway inhibitor plasma levels.
Dennis J, Kassam I, Morange PE, Trégouët DA, Gagnon F.
Thromb Haemost. 2015 Aug;114(2):245-57. doi: 10.1160/TH14-12-1043. Epub 2015 Apr 16.
Tissue factor pathway.
McVey JH.
Baillieres Best Pract Res Clin Haematol. 1999 Sep;12(3):361-72. doi: 10.1053/beha.1999.0030.
